Crossmark

Next generation of immune checkpoint therapy in cancer: new developments and challenges

Crossref DOI link: https://doi.org/10.1186/s13045-018-0582-8

Published Online: 2018-03-15

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Marin-Acevedo, Julian A.

Dholaria, Bhagirathbhai

Soyano, Aixa E.

Knutson, Keith L.

Chumsri, Saranya

Lou, Yanyan http://orcid.org/0000-0001-6207-9461
License Information

Text and Data Mining valid from 2018-03-15
More Information

Article History

Received: 6 December 2017

Accepted: 1 March 2018

First Online: 15 March 2018

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.